Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Eynde, Jean-Jacques Vanden
217  Ergebnisse:
Personensuche X
?
1

Potassium permanganate, a versatile reagent for the aromati..:

Eynde, Jean-Jacques Vanden ; D'Orazio, Rita ; Van Haverbeke, Yves
Tetrahedron.  50 (1994)  8 - p. 2479-2484 , 1994
Link: https://doi.org/10.1016/..
 
?
2

Novel Syntheses of Heterocycles with N-(1-Haloalkyl)azinium..:

Eynde, Jean-Jacques Vanden ; Mayence, Annie ; Maquestiau, André.
Synthetic Communications.  22 (1992)  22 - p. 3291-3304 , 1992
Link: https://doi.org/10.1080/..
 
?
3

Novel Syntheses of Heterocycles with N-(1-Haloalkyl)Azinium..:

Eynde, Jean-Jacques Vanden ; Mayence, Annie ; Maquestiau, André.
Synthetic Communications.  22 (1992)  21 - p. 3141-3150 , 1992
Link: https://doi.org/10.1080/..
 
?
4

Novel syntheses of heterocycles with N-(1-Haloalkyl)azinium..:

Eynde, Jean-Jacques Vanden ; D'Orazio, Patrizia ; Mayence, Annie..
Tetrahedron.  48 (1992)  7 - p. 1263-1268 , 1992
Link: https://doi.org/10.1016/..
 
?
5

An Improved One-Pot Method for the Preparation of 2-Substit..:

Maquestiau, André ; Berte, Laurence ; Mayence, Annie.
Synthetic Communications.  21 (1991)  21 - p. 2171-2180 , 1991
Link: https://doi.org/10.1080/..
 
?
6

Ultrasound-promoted aromatization of hantzsch 1,4-Dihydropy..:

Maquestiau, Andrè ; Mayence, Annie ; Eynde, Jean-Jacques Vanden
Tetrahedron Letters.  32 (1991)  31 - p. 3839-3840 , 1991
Link: https://doi.org/10.1016/..
 
?
7

Drugs and Drug Candidates: Year in Review:

Vanden Eynde, Jean Jacques
Drugs and Drug Candidates.  3 (2024)  1 - p. 52-53 , 2024
Link: https://doi.org/10.3390/..
 
?
8

Repositioning Oxybutynin Hydrochloride: State of the Art in..:

Vanden Eynde, Jean Jacques
Drugs and Drug Candidates.  2 (2023)  4 - p. 865-882 , 2023
Link: https://doi.org/10.3390/..
 
?
9

COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–..:

Vanden Eynde, Jean Jacques
Pharmaceuticals.  14 (2021)  7 - p. 664 , 2021
Link: https://doi.org/10.3390/..
 
?
10

2019: An Awesome Year for Pharmaceuticals:

Vanden Eynde, Jean Jacques
Pharmaceuticals.  13 (2020)  1 - p. 6 , 2020
Link: https://doi.org/10.3390/..
 
?
11

COVID-19: An Update about the Discovery Clinical Trial:

Vanden Eynde, Jean Jacques
Pharmaceuticals.  13 (2020)  5 - p. 98 , 2020
Link: https://doi.org/10.3390/..
 
?
12

Breakthroughs in Medicinal Chemistry: New Targets and Mecha..:

Gütschow, Michael ; Vanden Eynde, Jean Jacques ; Jampilek, Josef...
Molecules.  25 (2020)  13 - p. 2968 , 2020
Link: https://doi.org/10.3390/..
 
?
13

Dual-Target Inhibitors of the Folate Pathway Inhibit Intrin..:

Toulouse, Jacynthe L. ; Shi, Genbin ; Lemay-St-Denis, Claudèle...
ACS Medicinal Chemistry Letters.  11 (2020)  11 - p. 2261-2267 , 2020
Link: https://doi.org/10.1021/..
 
?
14

COVID-19: A Brief Overview of the Discovery Clinical Trial:

Vanden Eynde, Jean Jacques
Pharmaceuticals.  13 (2020)  4 - p. 65 , 2020
Link: https://doi.org/10.3390/..
 
?
15

Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhib..:

Mayence, Annie ; Vanden Eynde, Jean Jacques
Pharmaceuticals.  12 (2019)  1 - p. 37 , 2019
Link: https://doi.org/10.3390/..
 
1-15